The Investor Relations website contains information about CytoSorbents's business for stockholders, potential investors, and financial analysts.
Investor Relations. Overview · Events & Presentations · Analyst Coverage · Financial Results · Videos · SEC Filings · Stock Quote · Investor FAQ · Corporate ...
Get the latest Cytosorbents Corporation (CTSO) stock news and headlines to help you in your trading and investing decisions.
People also ask
Is CytoSorbents granted expanded Anvisa registration to treat shock with CytoSorb in Brazil?
Who makes CytoSorb?
Cytosorbents Corporation Common Stock is estimated to report earnings on 05/07/2024. The upcoming earnings date is derived from an algorithm based on a ...
Cytosorbents Corporation (NasdaqCM:CTSO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest ...
Jul 26, 2023 · (NASDAQ: CTSO), a leader in the treatment of life ... investor-relations/financial-results/. About CytoSorbents Corporation (NASDAQ: CTSO).
Find the latest Cytosorbents Corporation (CTSO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Find the latest information on Cytosorbents Corporation Common Stock (CTSO) insider activity and insider shares traded to make sound investments with ...
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Mar 14, 2024 · CytoSorbents reported positive financial results for the year 2023, with total revenue increasing by 5% to $36.3 million.